COUR Pharmaceuticals

COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance...

Tracy Weiner

General Counsel at COUR Pharmaceuticals

Leo Kelly

Executive Director, Strategic Alliances at COUR Pharmaceuticals

Brian Bock

CFO at COUR Pharmaceuticals

Michael Boyne

Vice President Of Product Development and Analytics at COUR Pharmaceuticals

Adam Elhofy

Vice President of Research and Collaborations at COUR Pharmaceuticals

Timothy Toby

Senior Consultant at COUR Pharmaceuticals

John Puisis

Founder, President and CEO at COUR Pharmaceuticals